"1p" Pill Images
The following drug pill images match your search criteria.
1 / 4
Loading
IPX066 145
Rytary
- Strength
- carbidopa 36.25 mg / levodopa 145 mg
- Imprint
- IPX066 145
- Color
- Blue
- Shape
- Capsule/Oblong

TYLENOL PM
Tylenol PM Extra Strength
- Strength
- acetaminophen 500 mg / diphenhydramine hydrochloride 25 mg
- Imprint
- TYLENOL PM
- Color
- Blue
- Shape
- Capsule/Oblong

ADIPEX-P 9 9
Featured

Wegovy
Wegovy (semaglutide) is an FDA-approved weekly injection for weight loss, reducing heart risks ...
Reviews & ratings

IPX203 280
Crexont
- Strength
- carbidopa 70 mg / levodopa 280 mg
- Imprint
- IPX203 280
- Color
- Purple / White
- Shape
- Capsule/Oblong
1 / 3
Loading
NORTRIPTYLINE DAN 10 mg
Nortriptyline Hydrochloride
- Strength
- 10 mg
- Imprint
- NORTRIPTYLINE DAN 10 mg
- Color
- Green / White
- Shape
- Capsule/Oblong

1 / 2
Loading
IP 116
Reprexain
- Strength
- hydrocodone bitartrate 2.5 mg / ibuprofen 200 mg
- Imprint
- IP 116
- Color
- White
- Shape
- Capsule/Oblong

1 / 7
Loading
LUPIN RAMIPRIL 10mg

VISTARIL PFIZER 541
Vistaril
- Strength
- 25 mg
- Imprint
- VISTARIL PFIZER 541
- Color
- Green / Green
- Shape
- Capsule/Oblong

NORTRIPTYLINE m 10 mg
Nortriptyline Hydrochloride
- Strength
- 10 mg
- Imprint
- NORTRIPTYLINE m 10 mg
- Color
- Green & White
- Shape
- Capsule/Oblong

1 / 2
Loading
IP 146
Reprexain
- Strength
- hydrocodone bitartrate 5 mg / ibuprofen 200 mg
- Imprint
- IP 146
- Color
- White
- Shape
- Oval

1 / 2
Loading
CIPLA 153
Valacyclovir Hydrochloride
- Strength
- 500 mg
- Imprint
- CIPLA 153
- Color
- Blue
- Shape
- Capsule/Oblong

1 / 4
Loading
800 IP 137
VIP101
Vilamit MB
- Strength
- hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg
- Imprint
- VIP101
- Color
- Purple
- Shape
- Capsule/Oblong
1 / 2
Loading
Cipla 25 mg 677

1 / 3
Loading
IP 114
Acetaminophen and Hydrocodone Bitartrate
- Strength
- 650 mg / 10 mg
- Imprint
- IP 114
- Color
- White
- Shape
- Capsule/Oblong

1 / 2
Loading
CIPLA 154
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.